Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
U.S. Stock Futures Drop Following Another Week Of Losses
09:14am, Tuesday, 05'th Jul 2022 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade on Tuesday after Wall Street recorded losses for another week and closed one of the worst halves in decades on Thursday. Howev
AstraZeneca to buy biotech firm TeneoTwo for up to $1.27 billion
08:15am, Tuesday, 05'th Jul 2022
AstraZeneca has agreed to buy biotech firm TeneoTwo in a deal worth up to $1.27, with Non-Hodgkin's lymphoma early-stage treatment at the heart of the deal.
7 Large-Cap Stocks With Sustained Dividend Growth Potential
06:01am, Tuesday, 05'th Jul 2022
Large-cap stocks that have strong cash flows and growth visibility that's likely to translate into sustained growth in dividends. The post 7 Large-Cap Stocks With Sustained Dividend Growth Potential a
Two vaccine stocks making headlines worth keeping an eye on
05:56am, Tuesday, 05'th Jul 2022
Anglo-Swedish drugmaker AstraZeneca (NASDAQ: AZN), announced on July 5, that they will acquire biotechnology firm TeneoTwo. The deal will be.
AstraZeneca to buy oncology firm TeneoTwo for up to $1.27 billion
02:34am, Tuesday, 05'th Jul 2022
AstraZeneca said on Tuesday it will acquire oncology firm TeneoTwo Inc in a deal worth up to $1.27 billion, including the company's initial stage T-cell engager.
AstraZeneca acquires blood cancer specialist TeneoTwo for up to US$1.2bn
02:30am, Tuesday, 05'th Jul 2022
AstraZeneca PLC (LSE:AZN) has struck a deal to swallow up a US-based owner of potential new drug cancer medicines for an initial U$S100mln (£82.6mln) and up to US$1.06bn in milestone payments. The FT
Oxford Biomedica signs new deal to make AstraZeneca COVID shot
10:15pm, Friday, 01'st Jul 2022
Britain's Oxford Biomedica announced an agreement to potentially make AstraZeneca's COVID-19 vaccine beyond 2022. It has already manufactured more than 100 million doses since 2020.
Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know
10:15pm, Friday, 01'st Jul 2022 Zacks Investment Research
Astrazeneca (AZN) closed at $65.95 in the latest trading session, marking a -0.18% move from the prior day.
AstraZeneca secures Covid-19 vaccine production amid safety concerns
11:21am, Friday, 01'st Jul 2022
AstraZeneca PLC (LSE:AZN) announced today that it had signed a new three-year agreement with Oxford BioMedica PLC (LSE:OXB) to manufacture the Covid-19 vaccine, amid concerns over the safety of the d
2 Healthcare Stocks That Could Help Set You Up for Life
03:07pm, Thursday, 30'th Jun 2022 The Motley Fool
These stocks could create significant wealth for shareholders in the long run.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
02:53pm, Thursday, 30'th Jun 2022 The Motley Fool
The U.S. economy could soon be heading into a recession.
2 Healthcare Stocks That Could Help Set You Up for Life
11:07am, Thursday, 30'th Jun 2022
These stocks could create significant wealth for shareholders in the long run.
4 Reasons Why Investors Should Buy Merck (MRK) Stock Now
01:17pm, Wednesday, 29'th Jun 2022 Zacks Investment Research
Strong sales of key products like Keytruda and Gardasil, a significant contribution from Lagevrio and a solid pipeline are some key reasons to own Merck's (MRK) stock.
Nuformix hoping to develop a 'bio-better' version of AstraZeneca blockbuster
02:54am, Wednesday, 29'th Jun 2022
Nuformix PLC (LSE:NFX) is developing a pre-clinical programme to further assess the potential of NXP004, a reformulation of AstraZeneca blockbuster cancer drug Lynparza. The aim of the work is to com
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
02:41pm, Tuesday, 28'th Jun 2022 Zacks Investment Research
The EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to AstraZeneca's (AZN) cancer drugs, Enhertu and Lynparza, for treating certain patients with breast can
